Skip to main content
. 2018 Aug 23;16(5):6147–6155. doi: 10.3892/ol.2018.9353

Figure 3.

Figure 3.

Survival curves of patients with OSCC and LSCC. Overall survival rates are presented according to the primary tumor site and p16INK4a status of (A) OSCC and (C) LSCC. Disease-free survival rates are presented according to the primary tumor site and p16INK4a status of (B) OSCC and (D) LSCC. OSCC, oral cavity squamous cell carcinoma; LSCC, larynx squamous cell carcinoma; p16INK4a, cyclin-dependent kinase inhibitor 2A.